<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang H</submitter><funding>Dell Medical School, University of Texas at Austin</funding><funding>Miami Project to Cure Paralysis</funding><funding>Office of Extramural Research, National Institutes of Health</funding><funding>Welch Foundation</funding><funding>Hope For Vision</funding><pagination>20753</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9715665</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>The sigma 2 receptor (σ&lt;sub>2&lt;/sub>R) was recently identified as an endoplasmic reticulum (ER) membrane protein known as transmembrane protein 97 (TMEM97). Studies have shown that σ&lt;sub>2&lt;/sub>R/TMEM97 binding compounds are neuroprotective, suggesting a role of σ&lt;sub>2&lt;/sub>R/TMEM97 in neurodegenerative processes. To understand the function of σ&lt;sub>2&lt;/sub>R/TMEM97 in neurodegeneration pathways, we characterized ischemia-induced retinal ganglion cell (RGC) degeneration in TMEM97&lt;sup>-/-&lt;/sup> mice and found that RGCs in TMEM97&lt;sup>-/-&lt;/sup> mice are resistant to degeneration. In addition, intravitreal injection of a selective σ&lt;sub>2&lt;/sub>R/TMEM97 ligand DKR-1677 significantly protects RGCs from ischemia-induced degeneration in wildtype mice. Our results provide conclusive evidence that σ&lt;sub>2&lt;/sub>R/TMEM97 plays a role to facilitate RGC death following ischemic injury and that inhibiting the function of σ&lt;sub>2&lt;/sub>R/TMEM97 is neuroprotective. This work is a breakthrough toward elucidating the biology and function of σ&lt;sub>2&lt;/sub>R/TMEM97 in RGCs and likely in other σ&lt;sub>2&lt;/sub>R/TMEM97 expressing neurons. Moreover, these findings support future studies to develop new neuroprotective approaches for RGC degenerative diseases by inhibiting σ&lt;sub>2&lt;/sub>R/TMEM97.</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>σ&lt;sub>2&lt;/sub>R/TMEM97 in retinal ganglion cell degeneration.</pubmed_title><pmcid>PMC9715665</pmcid><funding_grant_id>Grant</funding_grant_id><funding_grant_id>Support</funding_grant_id><funding_grant_id>R01EY023666; R01EY026643; R01EY031492; P30EY14801; NS098740; NS120028;</funding_grant_id><funding_grant_id>F-0652</funding_grant_id><funding_grant_id>Texas Health Catalyst program</funding_grant_id><pubmed_authors>Chou TH</pubmed_authors><pubmed_authors>Martin SF</pubmed_authors><pubmed_authors>Liebl DJ</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Wen R</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors><pubmed_authors>Peng Z</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Sahn JJ</pubmed_authors><pubmed_authors>Jiao S</pubmed_authors><pubmed_authors>Porciatti V</pubmed_authors><pubmed_authors>Hodges TR</pubmed_authors></additional><is_claimable>false</is_claimable><name>σ&lt;sub>2&lt;/sub>R/TMEM97 in retinal ganglion cell degeneration.</name><description>The sigma 2 receptor (σ&lt;sub>2&lt;/sub>R) was recently identified as an endoplasmic reticulum (ER) membrane protein known as transmembrane protein 97 (TMEM97). Studies have shown that σ&lt;sub>2&lt;/sub>R/TMEM97 binding compounds are neuroprotective, suggesting a role of σ&lt;sub>2&lt;/sub>R/TMEM97 in neurodegenerative processes. To understand the function of σ&lt;sub>2&lt;/sub>R/TMEM97 in neurodegeneration pathways, we characterized ischemia-induced retinal ganglion cell (RGC) degeneration in TMEM97&lt;sup>-/-&lt;/sup> mice and found that RGCs in TMEM97&lt;sup>-/-&lt;/sup> mice are resistant to degeneration. In addition, intravitreal injection of a selective σ&lt;sub>2&lt;/sub>R/TMEM97 ligand DKR-1677 significantly protects RGCs from ischemia-induced degeneration in wildtype mice. Our results provide conclusive evidence that σ&lt;sub>2&lt;/sub>R/TMEM97 plays a role to facilitate RGC death following ischemic injury and that inhibiting the function of σ&lt;sub>2&lt;/sub>R/TMEM97 is neuroprotective. This work is a breakthrough toward elucidating the biology and function of σ&lt;sub>2&lt;/sub>R/TMEM97 in RGCs and likely in other σ&lt;sub>2&lt;/sub>R/TMEM97 expressing neurons. Moreover, these findings support future studies to develop new neuroprotective approaches for RGC degenerative diseases by inhibiting σ&lt;sub>2&lt;/sub>R/TMEM97.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-25T17:09:23.389Z</modification><creation>2025-04-06T05:03:42.597Z</creation></dates><accession>S-EPMC9715665</accession><cross_references><pubmed>36456686</pubmed><doi>10.1038/s41598-022-24537-3</doi></cross_references></HashMap>